Author:
Semaan Salaam,Jarlais Don C., Ph.D. C. Des,Malow Robert M.
Reference231 articles.
1. Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment. Clinical Infectious Diseases. 2005;40:S330–S335.
2. Eotlin ER, Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases. 2005;40:S276–S285.
3. Des Jarlais DC, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology. 2003;157:467–471.
4. Murrill C, Weeks H, Castrucci B, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 U.S. cities. American Journal of Public Health. 2002;92: 385–387.
5. Des Jarlais DC, Friedman SR. Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have done, what we have not done. Public Health Reports. 1998;13:19–30.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献